The debate over whether naloxone should be as common as defibrillators

The man at the helm of the company that makes the life-saving opioid antidote naloxone says he wants to make the drug as common as defibrillators by stocking Narcan nasal spray with the devices in schools, community centresand arenas.

Opioid-relatedoverdoses killed 1,460 Canadians in the first half of last year and while more recent statistics aren't yet available, the Public Health Agency of Canada was predicting in December that the country was on pace to surpass 4,000 opioidoverdose deaths by the end of 2017.

• Opioid deaths in Canada expected to hit 4,000 by end of 2017

It's why David Renwick, the general manager of Adapt PharmaCanada, the manufacturer of naloxone, told CBC News that the life-saving drug should, like a fire extinguisher, be readily available in most public places.

'There's a problem right across the country'

"There's a problem right across the country," he said. "It doesn't seem to be limited to a stigma that we might have of people who are addicted to drugs, or perhaps living on the street or battling mental health issues, the reality is it's affecting all socio-economic profiles."

"It really needs to be tackled holistically," he said. "I think the one idea that stimulates that discussion is having these available in places where we have first aid kits, fire extinguishers or [with automated emergency defibrillators.]"

"The main driver here is 'how do we save lives?' I think the way we're trying to do that is looking for ways to make sure thatNarcanis as broadly available as possible."

Kingston city council voted to do exactly that,makingNarcannasal spray kits available at 14 public venuesacross the city as of Feb. 1, including swimming pools, museums, parks, a theatre and even the city airport.

'I think in theory it's a good idea'

Public schools inLambtonCounty and Chatham-Kent will also start carrying the drug, which reports say came after school officials took the advice of local health authorities to make it more readily available.

Paramedics in London, Ont., however, a city that hands out needles at a rate second only to Vancouver, think Kingston city officials and Lambton-Kenteducation officials might not be making the most pragmatic choice, especially when it comes to pairing the drug with an AED, or automated emergency defibrillatorin a public venue.

"I think in theory it's a good idea," Jay Looslie, the superintendent of education for Middlesex-London Emergency Medical Services said.

"We have a hard enough time having people find the AEDsand having them registered and being used, to add other things into it, I think would just confuse the public."

Another layer of difficulty

"We've been workingfor 20 plus years with the public to recognize where AEDsare, how to use them, how to even get them off the wall and not to be afraid of them and it's been really difficult," he said.

"We're not doing a lot of calls at high schools for narcotic overdoses," he said, noting most regular people wouldn't know the first thing about administering the opioid antidote.

"It's a drug and there are side-effects to drugs and giving to the wrong person, it does have its side effects," he said.

"I don't think having public accessNarcanin a school or a mall, in places I don't think it will really be used, just adds another layer of difficulty."

Paramedics say people at the scene of an opioidoverdose can save a life without Narcan, by keeping the victim's airways open until paramedics arrive.

"No one would ever associate an AED for cardiac arrest with a narcotic overdose," Looslie said."I just don't think you'll get best the bang for your buck."

Nalaxoneinjection kits free in Ontario

Nalaxone kits are currently available for free to anyone who asks for one from an Ontario pharmacist. The kit can deliver an inter-muscular injection of a life-saving dose of naloxoneto anyone suffering from an opioidoverdose.

If however, you were to ask for the same drug in its less intimidating nasal spray form, it would cost you more. Likely over $145 for a box of two doses, but the price is highly variable, according to Adapt PharmaGM David Renwick.

"It depends on the purchaser," Renwick said. "Depending upon which province you live, depending upon what's been worked out with governments. We do work with a purchaser to find a way to lower the cost."

"My hope is in the future we'll be able to provide a little more clarity of where the pricing is going to land."